191 related articles for article (PubMed ID: 27052730)
1. The clinical utility of an elevated-risk multivariate index assay score in ovarian cancer patients.
Eskander RN; Carpenter BA; Wu HG; Wolf JK
Curr Med Res Opin; 2016 Jun; 32(6):1161-5. PubMed ID: 27052730
[TBL] [Abstract][Full Text] [Related]
2. Low-risk multivariate index assay scores, physician referral and surgical choices in women with adnexal masses.
Dunton CJ; Eskander RN; Bullock RG; Pappas T
Curr Med Res Opin; 2020 Dec; 36(12):2079-2083. PubMed ID: 33107342
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?
Carney ME; Lancaster JM; Ford C; Tsodikov A; Wiggins CL
Gynecol Oncol; 2002 Jan; 84(1):36-42. PubMed ID: 11748973
[TBL] [Abstract][Full Text] [Related]
4. Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality.
Stewart SL; Townsend JS; Puckett MC; Rim SH
J Womens Health (Larchmt); 2016 Mar; 25(3):235-41. PubMed ID: 26978124
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of a multivariate index assay compared to modified American College of Obstetricians and Gynecologists criteria and CA-125 in the triage of women with adnexal masses.
Forde GK; Hornberger J; Michalopoulos S; Bristow RE
Curr Med Res Opin; 2016; 32(2):321-9. PubMed ID: 26588255
[TBL] [Abstract][Full Text] [Related]
6. Involvement of gynecologic oncologists in the treatment of patients with a suspicious ovarian mass.
Goff BA; Miller JW; Matthews B; Trivers KF; Andrilla CH; Lishner DM; Baldwin LM
Obstet Gynecol; 2011 Oct; 118(4):854-62. PubMed ID: 21934449
[TBL] [Abstract][Full Text] [Related]
7. A real-world comparison of the clinical and economic utility of OVA1 and CA125 in assessing ovarian tumor malignancy risk.
Reilly GP; Gregory DA; Scotti DJ; Lederman S; Neiman WA; Sussman S; M Bean L; Ekono MM
J Comp Eff Res; 2023 Jun; 12(6):e230025. PubMed ID: 37212790
[No Abstract] [Full Text] [Related]
8. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
Engelen MJ; Kos HE; Willemse PH; Aalders JG; de Vries EG; Schaapveld M; Otter R; van der Zee AG
Cancer; 2006 Feb; 106(3):589-98. PubMed ID: 16369985
[TBL] [Abstract][Full Text] [Related]
9. Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass.
Bristow RE; Hodeib M; Smith A; Chan DW; Zhang Z; Fung ET; Tewari KS; Munroe DG; Ueland FR
Am J Obstet Gynecol; 2013 Dec; 209(6):581.e1-8. PubMed ID: 23942039
[TBL] [Abstract][Full Text] [Related]
10. Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay.
Bristow RE; Smith A; Zhang Z; Chan DW; Crutcher G; Fung ET; Munroe DG
Gynecol Oncol; 2013 Feb; 128(2):252-9. PubMed ID: 23178277
[TBL] [Abstract][Full Text] [Related]
11. How relevant are ACOG and SGO guidelines for referral of adnexal mass?
Dearking AC; Aletti GD; McGree ME; Weaver AL; Sommerfield MK; Cliby WA
Obstet Gynecol; 2007 Oct; 110(4):841-8. PubMed ID: 17906018
[TBL] [Abstract][Full Text] [Related]
12. Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.
Coleman RL; Herzog TJ; Chan DW; Munroe DG; Pappas TC; Smith A; Zhang Z; Wolf J
Am J Obstet Gynecol; 2016 Jul; 215(1):82.e1-82.e11. PubMed ID: 26970494
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors.
Ueland FR; Desimone CP; Seamon LG; Miller RA; Goodrich S; Podzielinski I; Sokoll L; Smith A; van Nagell JR; Zhang Z
Obstet Gynecol; 2011 Jun; 117(6):1289-1297. PubMed ID: 21606739
[TBL] [Abstract][Full Text] [Related]
14. Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
Chan JK; Kapp DS; Shin JY; Husain A; Teng NN; Berek JS; Osann K; Leiserowitz GS; Cress RD; O'Malley C
Obstet Gynecol; 2007 Jun; 109(6):1342-50. PubMed ID: 17540806
[TBL] [Abstract][Full Text] [Related]
15. Rural disparities in surgical care from gynecologic oncologists among Midwestern ovarian cancer patients.
Weeks K; Lynch CF; West M; Carnahan R; O'Rorke M; Oleson J; McDonald M; Stewart SL; ; Charlton M
Gynecol Oncol; 2021 Feb; 160(2):477-484. PubMed ID: 33218682
[TBL] [Abstract][Full Text] [Related]
16. Validation of referral guidelines for women with pelvic masses.
Im SS; Gordon AN; Buttin BM; Leath CA; Gostout BS; Shah C; Hatch KD; Wang J; Berman ML
Obstet Gynecol; 2005 Jan; 105(1):35-41. PubMed ID: 15625139
[TBL] [Abstract][Full Text] [Related]
17. Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer.
Boac BM; Xiong Y; Apte SM; Wenham RM; Shahzad MM; Munroe DG; Lancaster JM; Chon HS
Am J Obstet Gynecol; 2018 Apr; 218(4):436.e1-436.e7. PubMed ID: 29353030
[TBL] [Abstract][Full Text] [Related]
18. Are too many imaging tests being performed in women with an adnexal mass?
Kupets R; Fernandes K; Miroshnichenko G; Paszat L
J Obstet Gynaecol Can; 2013 Mar; 35(3):246-251. PubMed ID: 23470112
[TBL] [Abstract][Full Text] [Related]
19. Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.
Miller RW; Smith A; DeSimone CP; Seamon L; Goodrich S; Podzielinski I; Sokoll L; van Nagell JR; Zhang Z; Ueland FR
Obstet Gynecol; 2011 Jun; 117(6):1298-1306. PubMed ID: 21555961
[TBL] [Abstract][Full Text] [Related]
20. Gynecologic Oncologist as surgical consultant: intraoperative consultations during general gynecologic surgery as an important focus of gynecologic oncology training.
Aviki EM; Rauh-Hain JA; Clark RM; Hall TR; Berkowitz LR; Boruta DM; Growdon WB; Schorge JO; Goodman A
Gynecol Oncol; 2015 Apr; 137(1):93-7. PubMed ID: 25617772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
